San Diego Union-Tribune (Sunday)
VENTILATOR MANUFACTURERS STRUGGLE TO MEET DEMAND
Hospitals desperate for devices crucial for treating illness
As the United States braces for an onslaught of coronavirus cases, hospitals and governments are confronting a grim reality: There are not nearly enough lifesaving ventilator machines to go around, and there is no way to solve the problem before the disease reaches full throttle.
Desperate hospitals say they can’t find anywhere to buy the medical devices, which help patients breathe and can be the difference between life and death for those facing the most dire respiratory effects of the coronavirus.
American and European manufacturers say they can’t speed up production enough to meet soaring demand, at least not anytime soon.
And while the acute shortages are global, not just in the United States, some European governments are deploying wartime-mobilization tactics to get factories churning out more ventilators — and to stop domestic companies from exporting them.
The United States, by contrast, has been slow to develop a national strategy for accelerating the production of ventilators.
Last week, President Donald Trump urged governors to find ways to procure new ventilators. “Try getting it yourselves,” he said.
On Friday, Trump said he invoked the Korean Warera Defense Production Act, which empowers the federal government to exert control over the private sector to meet national defense needs and ensure that supplies get to where they are most needed, regardless of the business plans of the companies involved.
At a White House news conference Saturday, Trump did not give examples of how he was using it, saying that his inclination was not to interfere with market forces. And because companies were voluntarily heeding his calls to action, he said it was unnecessary to apply the act.
Trump singled out General Motors and the Ford Motor Co. as among the many businesses that have asked to start making medical gear like ventilators, the need for which he said has grown into the hundreds of thousands.
“Nobody’s ever heard of a thing like that. With that being said, General Motors, Ford, so many companies — I had three calls yesterday directly, without having to institute like, ‘You will do this’ — these companies are making them right now,” Trump said.
Neither automaker, however, is building ventilators at present. GM announced on Friday that it is working with Ventec Life Systems, a small ventilator company with headquarters near Seattle.
The automaker said it would help with logistics, purchasing and manufacturing, but stopped short of saying it would make ventilators in its own factories, which have been idled for at least two weeks.
Ford, which also suspended factory production along with other automakers with operations in North America, confirmed that it too was in discussions with the Trump administration about helping.
“We’re looking at feasibility,” Ford spokesman T.R. Reid said. “It may be possible, but it’s not like you go from Rangers (small pickups) one day to ventilators the next. We’re figuring out what is possible now.”
Ford and Rolls-royce also are working with the British government to see if they can switch over their factories.
One of the world’s largest makers of ventilators, Hamilton Medical in Switzerland, is shipping machines as fast as it can to get them off the assembly line.
CEO Andreas Wieland said he has moved office workers to the factory and hired more employees. Even so, the company cannot keep up with the crush of orders.
“Italy wanted to order 4,000, but there’s not a chance,” he said. “We sent them something like 400.”
The coronavirus attacks people’s lungs, in some cases compromising their ability to breathe. Ventilators, which deliver air to the lungs through a tube placed in the windpipe, are a crucial tool to keep these patients alive. The computerized, bedside machines can cost as much as $50,000.
Hospitals in the United States have roughly 160,000 ventilators. There are a further 12,700 in the national strategic stockpile, a cache of medical supplies maintained by the federal government to respond to national emergencies.
That probably won’t be enough if the number of serious coronavirus cases keeps climbing.
“In a worst-case scenario it would be very difficult to have a sufficient number,” said Thomas R. Frieden, the director of the U.S. Centers for Disease Control and Prevention during the Obama administration.
In the United States, roughly half of the intensivecare ventilators in use were made by foreign companies, including Dräger and Getinge, according to estimates by ECRI, a nonprofit group that evaluates medical technology.
There are fewer than a dozen American companies — including giants like General Electric and Medtronic — that make ventilators, according to Greg Crist, a spokesman for Advamed, the trade group that represents American medical device makers. They are scrambling to accelerate production.
But the machines are complicated, made up of hundreds of smaller parts produced by companies all over the world. There is no simple way to substantially increase the output.
“We are in a global supply chain situation, like it or not, so everybody making ventilators here or elsewhere is going to be looking for parts, often coming from the same suppliers,” said Marcus Schabacker, chief executive of ECRI. “There’s a domino effect coming into play.”
Earl Refsland, chief executive of Allied Healthcare Products, a small ventilator manufacturer in St. Louis, said that ramping up production quickly was not possible. For his company, which makes about 1,000 ventilators a year, it will take at least eight months to sharply increase production.
“These are ventilators to keep people alive,” Refsland said. “We aren’t making wagon wheels. It takes a while.”
Demand has spiked just as countries are forcing people to stay home to slow the coronavirus’s spread. To bring more workers into factories, companies first need to buy protective gear for staff and spend money on cleaning services.
Without an adequate supply, doctors may have to make life-or-death decisions about who needs the machines most.
Johns Hopkins University’s hospital system bought some new ventilators a few weeks ago, when the leadership saw the coronavirus spreading. But the Baltimore hospital network is struggling to find more to buy.
“We’re scrounging,” said Gabe Kelen, director of Johns Hopkins’ office of critical event preparedness. “We’re looking at every possible place we might get one.”
The hospital system has considered whether it could work with the university’s engineering department to build its own ventilators — an option that Kelen described as “extreme,” given that they’ve never built the complex machines before — and has also convened a group of doctors and ethicists to figure out how to essentially ration the use of ventilators if there are more patients than machines.
As the initial epicenter of the coronavirus outbreak, China snapped up whatever slack there was in the market for the assisted-breathing machines. When the disease spread to South Korea and Italy, hospitals in those countries put their orders in. Now manufacturers are getting inundated with orders from all over the world.
The United States is toward the back of the queue, according to manufacturers.